CrowdStrike Holdings (CRWD) PT Lowered to $425 at Jefferies
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
CrowdStrike Holdings (CRWD) PT Raised to $415 at DA Davidson
March 5, 2025 7:46 AM ESTDA Davidson analyst Rudy Kessinger raised the price target on CrowdStrike Holdings (NASDAQ: CRWD) to $415.00 (from $395.00) while maintaining a Buy rating.
The analyst comments "CRWD beat FQ4 expectations across the board, including strong NNARR of $224M as reported vs.... More
Citi Reiterates Buy Rating on CrowdStrike Holdings (CRWD)
March 5, 2025 6:56 AM ESTCiti analyst Fatima Boolani reiterated a Buy rating and $420.00 price target on CrowdStrike Holdings (NASDAQ: CRWD)
The analyst comments "FY25 closed on a reasonable note all-things-outage considered, with ARR inline-ish as CCP uptake tracked slightly ahead, NRR compressing ~1pt worse than our 113%, but $6.5B RPO... More
JPMorgan Reiterates Overweight Rating on CrowdStrike Holdings (CRWD)
March 5, 2025 5:23 AM ESTJPMorgan analyst Brian Essex reiterated an Overweight rating and $450.00 price target on CrowdStrike Holdings (NASDAQ: CRWD)
The analyst comments "Solid 4Q results with line of sight into better normalized growth and profitability. CRWD delivered better-than-expected 4Q results with revenue, profitability and FCF all ahead of expectations. Results were supported by healthy traction from emerging products with Exposure Management a new emerging... More
